Related references
Note: Only part of the references are listed.Balancing the Benefits and Risks of Inhaled Long-Acting Beta-Agonists - The Influence of Values
Judith M. Kramer
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease - Results from the TORCH study
Bartolome R. Celli et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease - A systematic review and meta-analysis
Sonal Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Patterns of healthcare utilization by COPD severity: A pilot study
Min J. Joo et al.
LUNG (2008)
Arrhythmias in Patients With Chronic Obstructive Pulmonary Disease (COPD) Occurrence Frequency and the Effect of Treatment With the Inhaled Long-Acting Beta2-Agonists Arformoterol and Salmeterol
John P. Hanrahan et al.
MEDICINE (2008)
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database
Tim C. Clayton et al.
EUROPEAN HEART JOURNAL (2008)
Cardiac safety profile of nebulized formoterol in adults with COPD: A 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial
Harold S. Nelson et al.
CLINICAL THERAPEUTICS (2007)
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cardiac safety of formoterol 12 μg twice daily in patients with chronic obstructive pulmonary disease
Sammv C. Campbell et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2007)
Effects of nocturnal noninvasive mechanical ventilation on heart rate variability of patients with advanced COPD
Don D. Sin et al.
CHEST (2007)
Mortality in COPD: role of comorbidities
D. D. Sin et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Pooled clinical trial analysis of tiotropium safety
Steven Kesten et al.
CHEST (2006)
Meta-analysis:: Anticholinergics, but not β-agonists, reduce severe exacerbations and respiratory mortality in COPD
Shelley R. Salpeter et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2006)
Lung function decline and outcomes in an elderly population
D. M. Mannino et al.
THORAX (2006)
COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser permanente medical care program
S Sidney et al.
CHEST (2005)
Cardiovascular morbidity and mortality in COPD
L Huiart et al.
CHEST (2005)
Cardiovascular safety of salmeterol in COPD
GT Ferguson et al.
CHEST (2003)
Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study
P Buch et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease
DD Sin et al.
CIRCULATION (2003)
Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma?
T Ringbæk et al.
RESPIRATORY MEDICINE (2003)
Ventricular arrhythmias in patients with COPD are associated with QT dispersion
P Yildiz et al.
CHEST (2002)
Hospitalizations and mortality in the Lung Health Study
NR Anthonisen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Factors associated with the development of atrial fibrillation in COPD patients:: The role of P-wave dispersion
T Tükek et al.
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY (2002)
COPD may increase the incidence of refractory supraventricular arrhythmias following pulmonary resection for non-small cell lung cancer
Y Sekine et al.
CHEST (2001)
Long-acting β2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma -: A randomized controlled trial
SC Lazarus et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Use of sympathomimetic drugs leads to increased risk of hospitalization for arrhythmias in patients with congestive heart failure
ML Bouvy et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
beta-adrenergic modulation of human type-1/type-2 cytokine balance
SK Agarwal et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
Share Paper
